Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial

[1]  A. Woodcock,et al.  Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial. , 2014, The journal of allergy and clinical immunology. In practice.

[2]  A. Woodcock,et al.  Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial , 2014, Allergy.

[3]  British guideline on the management of asthma. , 2014, Thorax.

[4]  L. Tombs,et al.  The efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening dosing. , 2013, Respiratory medicine.

[5]  A. Allen.  The Relationship Between Fluticasone Furoate Systemic Exposure and Cortisol Suppression , 2013, Clinical Pharmacokinetics.

[6]  P. Bareille,et al.  Fluticasone Furoate, a Novel Inhaled Corticosteroid, Demonstrates Prolonged Lung Absorption Kinetics in Man Compared with Inhaled Fluticasone Propionate , 2012, Clinical Pharmacokinetics.

[7]  C. Crim,et al.  Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study. , 2012, Clinical therapeutics.

[8]  A. Woodcock,et al.  Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial. , 2012, Respiratory medicine.

[9]  J. Lötvall,et al.  Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial , 2012, BMJ Open.

[10]  A. Woodcock,et al.  Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma , 2011, Respiratory research.

[11]  I. Adcock,et al.  Long-acting fluticasone furoate has a superior pharmacological profile to fluticasone propionate in human respiratory cells. , 2011, European journal of pharmacology.

[12]  A. Woodcock,et al.  Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial , 2011, Respiratory research.

[13]  A. Woodcock,et al.  Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial , 2011, Thorax.

[14]  D. Price,et al.  Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study , 2010, BMC pulmonary medicine.

[15]  E. Bleecker,et al.  Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. , 2009, The Journal of allergy and clinical immunology.

[16]  V. Pavlov,et al.  Diurnal variations in human pulmonary function. , 2008, International journal of clinical and experimental medicine.

[17]  Kevin B Weiss,et al.  Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. , 2004, The Journal of allergy and clinical immunology.

[18]  British guideline on the management of asthma. , 2003, Thorax.

[19]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .